1. Home
  2. HSIC vs DVA Comparison

HSIC vs DVA Comparison

Compare HSIC & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Henry Schein Inc.

HSIC

Henry Schein Inc.

HOLD

Current Price

$79.92

Market Cap

9.1B

Sector

Health Care

ML Signal

HOLD

Logo DaVita Inc.

DVA

DaVita Inc.

HOLD

Current Price

$104.88

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HSIC
DVA
Founded
1932
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Misc Health and Biotechnology Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1B
8.2B
IPO Year
1995
1995

Fundamental Metrics

Financial Performance
Metric
HSIC
DVA
Price
$79.92
$104.88
Analyst Decision
Hold
Hold
Analyst Count
13
4
Target Price
$75.92
$145.00
AVG Volume (30 Days)
1.2M
799.0K
Earning Date
02-24-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
30.70
5.63
EPS
3.17
9.76
Revenue
$12,938,000,000.00
$13,317,965,000.00
Revenue This Year
$5.34
$6.50
Revenue Next Year
$3.42
$2.97
P/E Ratio
$25.24
$10.73
Revenue Growth
3.51
5.14
52 Week Low
$60.56
$101.00
52 Week High
$82.49
$179.60

Technical Indicators

Market Signals
Indicator
HSIC
DVA
Relative Strength Index (RSI) 64.64 29.58
Support Level $74.90 $101.00
Resistance Level $80.03 $106.38
Average True Range (ATR) 1.91 3.05
MACD -0.07 -0.77
Stochastic Oscillator 96.48 26.82

Price Performance

Historical Comparison
HSIC
DVA

About HSIC Henry Schein Inc.

Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

Share on Social Networks: